ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB1186

    A Bypass Surgery with Congenital Factor 5 and Factor 8 Deficiency

    V. Okan, H.H. Şahin, D.M. Akkurd

  • Abstract Number: PB0905

    A Canadian, Multi-Center, Retrospective, Non-Interventional Study of Clinical Outcomes from Early Use of N9-GP Compared with Previous Treatment in Patients with Hemophilia B in a Real-World Setting

    D. Matino1, A. Iorio1, A. Keepanasseril1, F. Germini2, A.C. Birkegård3, A. Caillaud4, M. Carcao5, J. Hews-Girard6, E. Iserman7, P. James8, A. Lee9, C. Phua10, H. Sun11, J. Teitel12, M.-C. Poon13

  • Abstract Number: PB0008

    A Case Report of a Patient with Hereditary Angioedema and Samter´s Syndrome Treated with Anticoagulant of Direct Action Anti Xa (Rivaroxaban), Secondary to Angioplasty due to Ischemic Heart Disease

    B.S. Zuñiga Ascencio1,2, F. Vidal Martinez3, M. Castillejos López4, B.A. Lira Mendoza5, M.E. Jaime Capetillo5, E. Juárez Silva5, R. Guevara Gutiérrez5

  • Abstract Number: PB2454

    A Case Report of Deep Vein Thrombosis after Kidney Transplantation

    I. Puspitawati1, I. Kuswadi2, Y. Wardhani2, T. Widodo3

  • Abstract Number: PB0711

    A Case Report of Spontaneous and Recurrent Arterial and Venous Thrombotic Events in a Child with FGA c.1372C>T Mutation

    H. Yixuan, W. Runhui, Z. Rui, Y. Jiafeng

  • Abstract Number: PB1432

    A Challenging Case of Delayed-onset Refractory Heparin-induced Thrombocytopenia Complicated with Arterial Thrombosis

    S. Van de Vondel

  • Abstract Number: PB1305

    A Child with Ischemia of the Glans Penis after Circumcision

    L.D. Rahmartani1, G.R. Situmorang2, T.T. Sari1, I. Wahyudi2

  • Abstract Number: PB1609

    A Close Relationship between Adipocytes and Megakaryocytes

    C. Valet, A. Batut, A. Vauclard, A. Dortignac, M. Bellio, B. Payrastre, P. Valet, S. Severin

  • Abstract Number: PB2283

    A Combination of Age Adjusted Cut-Off and Preanalytical Conditions Monitoring for Increased DDIM Assay Specificity

    J. Prochazkova, L. Slavik, J. Ulehlova, J. Kaminkova, P. Chalupnikova, V. Krcova, A. Hlusi

  • Abstract Number: PB0856

    A Comparative Analysis of the Immune Response to Homologous Coagulation Factors V and VIII

    M.L. Sauer1, A.R. Wilhelm1, R.J. Davidson1, L.A. George1,2, R.M. Camire2,3

  • Abstract Number: PB0201

    A Comparison of Mass and Potency Equated Bovine and Porcine Heparins

    S. Krishnappan, F. Siddiqui, A. Farooqui, O. Iqbal, A. Kouta, D. Hoppensteadt, W. Jeske, J. Walenga, J. Fareed

  • Abstract Number: PB0670

    A Correlation of Thrombin Generation Assay and Clot Waveform Analysis in Patients on Warfarin

    M.A. Cheong, C.W. Tan, W.H. Wong, M.C. Kong, E. See, S.H. Yeang, S.K. Koh, Y.T. Shim, L.H. Lee, H.J. Ng

  • Abstract Number: PB0248

    A Critical Role of Carboxyl-Terminal Alpha-Helix in the Secretion of Coagulation Factor XI

    Y. Hayakawa1, S. Tamura1, N. Suzuki2, K. Odaira1, M. Tokoro1, F. Kawashima1, F. Hayakawa1, A. Takagi1, A. Suzuki3, S. Okamoto4, T. Kanematsu3, T. Matsushita2,3, T. Kojima1,5

  • Abstract Number: PB2335

    A Decade of Experience in Peripherally Inserted Central Catheter (PICC) Related Thrombosis in Hematological Malignancies of a Single Spanish Center

    E. Sobejano1, M. Fonseca1, M. Baile1, M. Vaquero2, B. Rey1, V. Higuero1, M. Sastre1, O. del Rey1, B. Perez1, M. de la Iglesia1, H. Sanchez1, R. Garcia1, I. Rodriguez1, D. Sanchez1, J.R. Gonzalez Porras1, J.M. Bastida1

  • Abstract Number: PB1075

    A Descriptive Study of Physical Activity and Fitness Level Profiles of Nigerians with Haemophila

    H. Okoye1, T. Nwagha1, N. Chigbo2, E. Anekwu3

  • Abstract Number: PB1196

    A Digestive Hemorrhage Like No Other

    Y. Cherif, S. Hamrouni, M. Mrouki, S. Derbel, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB0189

    A Double Heterozygous Factor VII (FVII) Deficiency: Exon 9 Missense Mutation (Arg364Gln – FVII Padua) and a Novel Exon 3 Missense Mutation (Ala87Gly)

    C. Gallardo1, C.L.L. Sum1, L.J.L. Wong1, K.H. Ong1, L.L. Goh2

  • Abstract Number: PB0889

    A French Multicentre Prospective, Non-Interventional Study (B-SURE) Evaluating Real-World Usage and Effectiveness of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in People with Haemophilia B: Baseline Data

    H. Chambost1, B. Wibaut2, A. Borel Derlon3, S. Claeyssens4, S. Castet5, R. d'Oiron6,7, C. Negrier8, H. Andersson9, S. Bergenstråle9, C. Gandossi10, C. Martinez10

  • Abstract Number: PB0859

    A Generic Recombinant Factor VIIa Is Comparable to the Branded Novoseven in In-vitro and Pharmacokinetic Studies in Primates

    M. Iacobelli1, N. Sadeghi1, A. Kouta1, R. Duff2, O. Iqbal1, D. Hoppensteadt1, W. Jeske1, J. Walenga1, J. Fareed1

  • Abstract Number: PB0732

    A Genetic Modifier of Venous Thrombosis in Zebrafish Reveals a Functional Role for Fibrinogen AαE in Early Hemostasis

    R.J. Fish1, C. Freire1, R. Vilar2, C. Di Sanza1, S.J. Grzegorski3, C.E. Richter4, J.A. Shavit3, M. Neerman-Arbez1

  • Abstract Number: PB0393

    A Hereditary Bleeding Disorder Caused by a Novel Homozygous Mutation of Thrombomodulin Gene

    M. Osada1, K. Maruyama2, K. Kokame2, R. Denda1, K. Yamazaki1, H. Kunieda1, M. Hirao1, S. Madoiwa3, N. Okumura4, M. Murata5, Y. Ikeda6, Y. Tsukada1, T. Kikuchi1

  • Abstract Number: PB1731

    A Humanised CLEC-2 Mouse Model to Study Anti-Human CLEC-2 Biologics in vivo

    H. Brown1, S. Navarro1, Y. Di2, S. Thomas2, S. Watson2, B. Nieswandt1, D. Stegner1

  • Abstract Number: PB1365

    A Long Term Survival Chronic DIC with ITP Treated with Low Dose Steroid

    Y. Seki, O. Nagano

  • Abstract Number: PB/CO05

    A Low Dose Heparin Protocol Is Associated with Improved Duration of Arterial Line Patency in Critically Ill COVID-19 Patients

    L. Maurer1, C. Luckhurst1, A. Hamidi2, K. Newman2, M. Barra2, M. El Hechi3, A. Mokhtari3, K. Breen3, L. Lux4, L. Prout4, J. Lee3,5, E. Bittner6, D. Chang1,7, H. Kaafarani3, R. Roberts2, R. Rosovsky8

  • Abstract Number: PB0414

    A Membrane-Adjacent Region in Tissue Factor Provides Substrate Selectivity

    F. Birkle1, J.H. Morrissey1,2

  • Abstract Number: PB1229

    A Multi Centre Non-randomised Clinical Trial to Establish the Efficacy of Peer Reviewed Physiotherapy Treatment Protocols among PWH in India

    P. Narayan

  • Abstract Number: PB0295

    A Multicenter Experience with Idarucizumab “In Real World” as Reversal Anticoagulation of Dabigatran

    I. Amarilla Lanzas1, N. Fernández Mosteirín2, J.M. Calvo Viñas2, L.I. Sancho Val3, I. Cuesta Gallardo4, O. Gavín Sebastián3

  • Abstract Number: PB1034

    A Multicenter Open-label Single Arm Trial to Evaluate Safety and Efficacy and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (SCT800) in Previously Treated Patients with Severe Hemophilia A under Prophylaxis Therapy

    W. Liu1, X. Zhao2, F. Xue1, J. Sun3, X. Zeng4, F. Yang5, Z. Yu6, M. Xu7, W. Li8, W. Gu9, Y. Feng10, C. Zheng11, H. Bi12, R. Yang1

  • Abstract Number: PB0802

    A Multicenter Prospective Validation Study on Disseminated Intravascular Coagulation in Trauma-Induced Coagulopathy

    S. Gando1, A. Shiraishi2, T. Wada3, K. Yamakawa4, T. Mayumi5, Y. Otomo6, JAAM Forecast

  • Abstract Number: PB0799

    A New Classification of Sepsis-Associated Disseminated Intravascular Coagulation (DIC) Based on Comprehensive Evaluation of Coagulation and Fibrinolysis

    T. Onishi1, K. Nogami1, T. Ishihara1, S. Inoue2, M. Kawaguchi2, K. Nishio3, H. Fukushima4, H. Kobayashi5, I. Amano6, T. Nishikubo7, M. Yamasaki8, M. Kasahara9, M. Shima1

  • Abstract Number: PB0735

    A New Genetic Alteration in Fibrinogen Gene with a Direful Phenotype: A Tie-in in a Newborn

    T. Nafees, Bleeding Disorder Working Group

  • Abstract Number: PB2229

    A New Global Assay for Detection of Protein C Pathway-Associated Thrombophilia Using Thrombomodulin-Mediated Clot Waveform Analysis

    N. Hashimoto, K. Ogiwara, K. Nogami, M. Shima

  • Abstract Number: PB0326

    A New Test Set up to Dose Factor VIII Ability to Bind Exogenous VWF

    F. Mori1, C. Genuardo1, A. Caricasole1, M. Grimaux2, O. Kerleau2, O. Mathieu2, S. Natelli2, T. Hervé3, F. Depasse3, P. Fuligni4, A. Juif5

  • Abstract Number: PB2136

    A Newly Developed Kit for High-Sensitivity Measurement of TF-Dependent Procoagulant Activity on Microvesicles Purified by High-Speed Centrifugation

    T. Bouriche1, C. Judicone1, C. Franco1, L. Vallier2, V. Cucini3, O. Mathieu2, F. Dignat-George4, R. Lacroix4, P. Poncelet1

  • Abstract Number: PB1144

    A Next Generation Recombinant Factor VIII for Subcutaneous Hemophilia A Prophylaxis

    P. Herbener1, J. Schüttrumpf2, J. Daufenbach1, S. Kistner1

  • Abstract Number: PB2301

    A Non-invasive Diagnostic Work-up Is Safe and Efficient to Exclude Pulmonary Embolism in Low Risk Pregnant Women with Suspected Pulmonary Embolism: A Systematic Review and Meta-analysis

    M. Stals1, T. Moumneh2, D. Aujesky3, L. Bertoletti4, I. Bistervels5, F. Couturaud6, A. Elias7, G. Le Gal6, M.V. Huisman8, A.T.A. Mairuhu9, S. Middeldorp5, L.M. van der Pol8, M. Righini10, H. Robert-Ebadi10, P.-M. Roy2, O. Sanchez11, M. van Smeden8, J. Schmidt12, C. Tromeur6, F.A. Klok8, on behalf of the CT-PE-Pregnancy Group and Artemis Investigators

  • Abstract Number: LB/CO01.1

    A Novel Adeno Associated Virus (AAV) Gene Therapy (FLT180a) Achieves Normal FIX Activity Levels in Severe Hemophilia B (HB) Patients (B-AMAZE Study)

    P. Chowdary1,2, S. Shapiro3, M. Makris4, G. Evans5, S. Boyce6, K. Talks7, G. Dolan8, U. Reiss9, M. Phillips1, A. Riddell1, M.R. Peralta1, M. Quaye2, E. Tuddenham1, J. Krop10, G. Short11, S. Kar11, A. Smith11, A. Nathwani1,2

  • Abstract Number: PB0223

    A Novel Coagulation Factor VIII with Reduced Immunogenicity

    K. Winterling1, W. Martin2, A.S. De Groot2, J. Daufenbach1, J. Schüttrumpf3, S. Kistner1

  • Abstract Number: OC 05.2

    A Novel Contact Pathway Inhibitor Improves Hemostasis and Maintains Circuit Patency in a Piglet Model of Pediatric ECMO

    C. Reed1, D. Bonadonna2, G. McDaniel3, J. Otto1, J. Frederiksen1, C. Chabata1,4, B. Sullenger1, E. Tracy1

  • Abstract Number: PB1147

    A Novel FVIIIa-Mimetic Bispecific Antibody, Mim8, Enhances FIXa Proteolytic Activity While Allowing for Efficient, Lipid-Dependent Assembly with FX

    J. Lund, H. Østergaard, P.J. Greisen, A.C. Bonde, P.S. Gandhi, N. Lorenzen, E. Johansson, L.M. Andersen, M.G. Rasch, S. Lund, R. Zhou, J.R. Bjelke, G. Røder, L.B. Johnsen, F. Stavenuiter, T. Egebjerg, A. Henriksen, B.G. Hansen, K. Thorn, I. Hilden

  • Abstract Number: PB1097

    A Novel Human Factor VIII Variant Exhibits Increased Factor VIII Expression after AAV Gene Therapy in a Unique Hemophilia A Dog Model that is Tolerant to Human Factor VIII

    G. Nguyen1, E. Merricks2, T. Long2, K. Ponder3, T. Nichols2, D. Sabatino1,4

  • Abstract Number: PB1599

    A Novel Image-Based Chemical-Genetics Screen Identifies Inducers of Platelet Release from Immortalized Megakaryocytic Cell Lines, Enabling Clinical-Scale Production of Functional Platelets

    A. Bhan1, N. Kareddy2, E. Forde2, G. Merrill-Skoloff3, B. Furie3, A. Frelinger2, G. Daley1, T. Schlaeger1

  • Abstract Number: PB0410

    A novel Interaction between Coagulation Factor XI and its Activated Form, FXIa, with the Complement Protein Properdin

    S.L. Heal1, L.J. Hardy1, C. Wilson1, M. Ali1, R. Ariëns1, R. Foster2, H. Philippou1

  • Abstract Number: PB1677

    A Novel Methodology to Study αIIbβ3 Interactions with Polymerizing Cross-linked Fibrin

    C. Buitrago, B. Coller

  • Abstract Number: PB1434

    A Novel Missense Mutations of the WASp Gene Cause a Familial X-linked Thrombocytopenia

    H. Liu1, J. Ma1, R. Wu2

  • Abstract Number: OC 14.1

    A Novel Neutrophil Extracellular Traps (NETs) Assay Predicts DIC and Stratifies Patients with Sepsis for Anti-IL-8 Therapy

    S. Abrams1, B. Morton2,3, Y. Alhamdi1, M. Alsabani1, Z. Cheng1,4, S. Lane5, I. Welters6,7, G. Wang1, C.-H. Toh1,8

  • Abstract Number: PB0641

    A Novel Point-of-Care Whole Blood Coagulation Assay to Screen for Hemostatic Defects

    S. Pourang1, M. Suster1, D. Maji1, S. Butala2, J. Nutt1, L. Nayak1,3, P. Mohseni1, S. Ahuja1,2

  • Abstract Number: PB0169

    A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs

    W. Sanrattana1, S. Smits1, D. Monroe2, C. Maas1, S. de Maat1

  • Abstract Number: PB0660

    A Novel Quantitative Chromogenic Fibrinogen Assay Adaptable to Centralized Laboratory Analyzers

    S. Pun1, N. Nienhold1, A. Ritschl1, M. Janssen1, A. Casini2

  • Abstract Number: PB0158

    A Novel Rare C. – 39C>T Mutation in the PROS1 5’UTR Causes Protein S Deficiency by Creating a New Upstream Translation Initiation Codon and an Overlapping Open Reading frame

    B. Jaspard-Vinassa1, C. Proust2,3, O. Soukarieh2,3, C. Mouton4, Y. Huguelin4, M. Roux5, J. Constans6, A. Boland7, R. Olaso7, J.-F. Deleuze7, P.-E. Morange8, S. Labrouche-Colomer1,4, D.-A. Trégouët2,3, GENMED Consortium

  • Abstract Number: PB1669

    A Novel Reporter Mouse Line Enables in vivo Imaging of Intracellular Calcium Fluxes in Platelets

    V. Klaus1, C. Gross1, S. Beck1,2, D. Stegner1,2

  • Abstract Number: PB0793

    A Novel Therapeutic Approach for Acute Thrombo-hemorrhagic Disorders Evoked by Snake Venom: Potential of Rutin and Rutin Succinate

    A.T.A. Sachetto1, A.O. de Souza2, M.L. Santoro1

  • Abstract Number: PB1220

    A Nurse Led Service Providing Safe and Effective Peri-Operative Anticoagulation

    P. Priest, A. Kadam, L. Moghaddam, N. Kashani, A. Drebes, P. Morjaria, S. Bates

  • Abstract Number: PB0608

    A Performance Evaluation of Chemiluminescent-Enzyme Immunoassays on a Routine Coagulation Analyser

    C. Gardiner1, P. Lane1, H. Tailor2, S.J. Machin1, I.J. Mackie1

  • Abstract Number: PB1806

    A Potential Role for the FcγRIIa in Vinorelbine Induced Thrombocytopenia and Neutropenia

    J.K. Au Yong1, Y. Parpia2, K. Golla3, J. Ni Gabhann4, L. Arkins5, D. Cox4, M. Brennan4

  • Abstract Number: PB2274

    A Practical Comparison of a PE Diagnostic Approach: Is All Wells in the World?

    L. Gerstein, M. Koolian, B. Schwartz

  • Abstract Number: PB2357

    A Prospective Observational Multicentre Study to Assess the Incidence of and Risk Factors for (T) Thrombosis (I) in Patients with (L) Lower (L) Limb (I) Injuries (R) Requiring (I) Immobilisation in Ireland (TILLIRI)

    D. O'Keeffe1, F. Ni Ainle2, T. Breslin2, A. Burke3, N. Salter4, S. O'Rourke5, A. Kruis6, A. Wakai7, S. Ahmed8, E. Turcuman2, E. Siobhan1, M. Watts1

  • Abstract Number: PB0896

    A Randomized Controlled Trial: Pharmacokinetic-Guided Dosing of Factor VIII Concentrate Versus Standard Replacement Therapy in Perioperative Hemophilia A Patients (OPTI-CLOT Trial)

    I. van Moort1, T. Preijers2, L. Bukkems2, H. Hazendonk1, B. Laros-van Gorkom3, E. Beckers4, L. Nieuwenhuizen5, F. van der Meer6, P. Ypma7, M. Coppens8, K. Fijnvandraat9,10, R. Schutgens11, K. Meijer12, F. Leebeek13, R. Mathot2, M. Cnossen1, OPTI-CLOT Study Group

  • Abstract Number: PB0957

    A Randomized, Multicenter, Open-label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Persons with Hemophilia A in the Asia-Pacific region (HAVEN 5)

    S. Wang1, X. Zhao2, X. Wang3, J. Sun4, A. Chuansumrit5, J. Zhou6, L. Li7, W. Hsu7, J. Xu7, P. Barrington8, R. Yang9

  • Abstract Number: PB0774

    A Rare Case of Acquired Haemophilia A with Platelet Dysfunction Associated with Non Hodgkin Indolent Lymphoma

    R. Rossio1, R. Cassin2, A. Lecchi1, A. Noto2, C. Novembrino1, M.E. Mancuso1, B. Ferrari1, G. Reda2, F. Peyvandi1,3

  • Abstract Number: PB1302

    A Rare Case of Phlephlebitis; An Unusual Underlying Reason for Portal Venous Thrombosis

    S. Aytac1, N. Korgal2, H. Hizacioglu3, A. Yuce3, F. Gumruk1

  • Abstract Number: PB0875

    A Real-World Qualitative Analysis of the Burden of Hemophilia B and Patient Experiences with Prophylactic Nonacog Beta Pegol

    C. Phua1, M. Faurby2, V. Macdonald3, J. Lambert4, J. Teitel5

  • Abstract Number: PB0093

    A Recurrent Ischaemic Stroke Case with Type 1 von Willebrand Disease

    H.H. Şahin, D.M. Akkurd, V. Okan

  • Abstract Number: PB2255

    A Retrospective Cohort Study on Splanchnic Vein Thrombosis

    E. Kawata (Iida)1,2, D.-A. Siew1,3, J. Payne3, A. Xenocostas1,3, M. Louzada1,3, M. Kovacs1,3, A. Lazo-Langner1,3,4

  • Abstract Number: PB2315

    A Retrospective Study of Incidence of Venous Thromboembolism (VTE) and Prevalence of Risk Factors Associated with VTE in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience

    B. Ram S, K.S. Nataraj, S. Prabhu, H. Dalal, A. Polisetty, S. Kumar, A. Shah, R.G. Karthick, M. Harimadhavan, S. Damodar

  • Abstract Number: PB1551

    A Retrospective Study to Evaluate the Efficacy and Safety of a Plasma-Derived, von Willebrand Factor-Containing FVIII Concentrate, in Patients with Von Willebrand Disease (VWD) in Spain: Interim Analysis Results

    V. Jiménez-Yuste1, R. Mir2

  • Abstract Number: PB1311

    A Rise in Plasma Coagulability During the First 3 Months Following Provoked Venous Thromboembolism is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

    M. Betensky1, E. Amankwah1, S. Brandal2, A.D. Everett2, N.A. Goldenberg1

  • Abstract Number: PB0224

    A Sensitive and Specific Assay to Measure TF Activity in Cell-derived Extracellular Vesicles Based on Thrombin Generation

    B. Østerud, N. Latysheva, O. Snir, J.-B. Hansen

  • Abstract Number: PB1166

    A Simple Algorithm to Identify Emicizumab Interference in Samples Received in the Clinical Coagulation Laboratory

    B. Poirier, E. McEwan, M. Robinson, R. Gode, S. Tiefenbacher

  • Abstract Number: PB1053

    A Simplified Health Education Program Improves Knowledge and Practices of Home Treatment in Hemophilia A Adolescents in a Developing Country

    T. Hassan1, M. Hesham1, A. El Dakhakhny2, M. Zakaria1, M. Hanfy2

  • Abstract Number: PB2285

    A Simplified Management Strategy for Suspected Pulmonary Embolism: External Validation of the YEARS Diagnostic Algorithm

    M. Eddy1, L. Richardson2, T. Moumneh3, G. Meyer4, M. Righini5, G. Le Gal6, H. Robert-Ebadi5

  • Abstract Number: PB0953

    A Single Center Data on Extended Half-Life Recombinant Factor VIII (FVIII:Fc) in Patients with Hemophilia A

    S. Braham1, R. Gualtierotti2, E. Biguzzi1, S.M. Siboni1, E. Bregani3, M. Boscarino4, M.E. Mancuso1, F. Peyvandi1,2

  • Abstract Number: PB2481

    A Single Centre Experience on the Use of Direct Oral Anticoagulants in People with Human Immunodeficiency Virus (HIV)

    S. Patel1, A. Godfrey2

  • Abstract Number: PB2321

    A Single-Centre Case Series of Venous Thromboembolic Disease

    J. Portillo Sánchez1, V. Quero Palomino2

  • Abstract Number: PB0382

    A Single-Domain Antibody that Exerts an Anticoagulant Effect Dependent on Protein S

    J.-C. Sedzro1, F. Adam1, A. De Carvalho1, I. Peyron1, E. Bianchini1, S. Gandrille2, S. Thomassen3, T.M. Hackeng3, O.D. Christophe1, P.J. Lenting1, C.V. Denis1, D. Borgel1,4, F. Saller1

  • Abstract Number: PB1062

    A Snapshot of a Prospective, Non-interventional Study to Evaluate Routine Practice Prophylactic Treatment Schedules – NIS-Previq

    S. Halimeh1, W. Behnisch2, C. Escuriola-Ettingshausen3, J. Feddern4, A. Huth-Kühne5, J. Oldenburg6, U. Scholz7, S. Seeger4, S. Wenning5, R. Klamroth8

  • Abstract Number: PB0595

    A Strategy for the Prenatal Diagnosis for Fetus with Hemophilia A without Genetic Defects

    Y. Li1, W. Jin1, Q. Li2, L. Li1

  • Abstract Number: PB0312

    A Strategy of Continued Antiplatelet Agents, Vitamin K Antagonists, and Direct Oral Anticoagulants throughout the Perioperative Period of Diabetic Foot Surgery in Patients Receiving Chronic Antithrombotic Therapy

    Y. Volkova1, D. Dmytriiev2

  • Abstract Number: PB0052

    A Study on Pressure Overload-Induced Cardiac Hypertrophy Model in Mice by Applying Transverse Aortic Constriction and O-Ring Ascending Aortic Banding Technique: A Comparative Analysis

    A. Rashid1,2

  • Abstract Number: PB1369

    A Subpopulation of ITP Patients Resembling Glanzmann Thrombasthenia Phenotype Revealed by Flow Cytometry Analysis of Platelet Intracellular Signalling

    A. Martyanov1,2,3, D.S. Morozova4, S.S. Uzueva3, M.A. Sorokina3, D.V. Fedorova3, P.A. Zharkov3, M.A. Panteleev2,3,5, A.N. Sveshnikova2,3,5

  • Abstract Number: PB2269

    A Systematic Review and Meta-Analysis on Diagnostic Delay in Pulmonary Embolism

    E.M. Trinks-Roerdink, R. van Maanen, G.J. Geersing

  • Abstract Number: PB0623

    A Universal Quality Control Plasma for Anti-Xa and Anti-IIa Drugs

    L. Pozzi1, E. Pattarini2, P. Della Valle3, A. D'Angelo3

  • Abstract Number: PB1777

    A Validated Model for the Diagnosis of Periprosthetic Joint Infection with Coagulation-related Markers: TGT and NETs

    J. Oto1, Á. Fernández-Pardo1, M. Fuertes2, M.J. Solmoirago1, E. Plana1, D. Hervás3, F. Cana1, C. De la Calva2, M. Angulo2, I. Baixauli2, F. Baixauli2, F. España1, S. Navarro1, J.V. Amaya2, P. Medina1

  • Abstract Number: PB1485

    A Whole Blood Flow Cytometric Method for Diagnosis of Platelet Function Disorders

    R.G. Dave1, T. Geevar1, R. V.1, S. Singh1, A. Abraham2, A. Srivastava2, S.C. Nair1

  • Abstract Number: PB0954

    Abdominal Catastrophe in Hemophilic Patients: Towards Wise Decision Making

    M. Abdelkader Morad, M. Elkholy, M. Mattar, M. Hasab Allah, A. Ayad, S. Habib, G. Nashed

  • Abstract Number: PB2558

    ABO Blood Groups and Inherited Thrombophilia in Women with Abortion

    A. Poretto, L. Spiezia, E. Borella, G. Turatti, M. Marobin, E. Campello, P. Simioni

  • Abstract Number: PB0041

    Absence of Protein Tyrosine Phosphatase-1B in Smooth Muscle Cells Promotes Perivascular Fibrosis: Role of Receptor Tyrosine Kinase Signaling

    S. Gachkar, D. Velmeden, T. Münzel, K. Schäfer

  • Abstract Number: PB1614

    Accelerated Death of Wiskott-Aldrich Syndrome Megakaryocytes

    S. Obydennyi1,2, O. Fedyanina1,2, S. Kuznetsova1,2, A. Khoreva2, F. Ataullakhanov1,2,3, A. Shcherbina2, M. Panteleev1,2,3

  • Abstract Number: PB0586

    Accuracy of Commercial Universal Calibrators for Measurement of Heparin and Low Molecular Weight Heparin

    J. Hogwood, E. Gray

  • Abstract Number: OC 10.3

    Accurate and Efficient Non-Invasive Strategy for Early Identification of Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism (InShape II Study)

    G.J.A.M. Boon1, Y.M. Ende-Verhaar1, R. Bavalia2, L.H. El Bouazzaoui3, M. Delcroix4, O. Dzikowska-Diduch5, M.V. Huisman1, K. Kurnicka5, A.T.A. Mairuhu6, S. Middeldorp7, P. Pruszczyk5, D. Ruigrok8, P. Verhamme9, H.W. Vliegen10, A. Vonk Noordegraaf8, J.W.J. Vriend11, F.A. Klok1

  • Abstract Number: PB1754

    Acetyl-CoA Carboxylase Inhibition Alters Tubulin Acetylation and Aggregation in Thrombin-stimulated Platelets

    M. Octave1, A. Ginion1, L. Pirotton1, V. Robaux1, S. Lepropre1, S. Kautbally1, V.M. Darley-Usmar2, J. Ambroise3, B. Guigas4,5, M. Giera6, M. Foretz7, L. Bertand1, C. Beauloye1, S. Horman1

  • Abstract Number: PB1759

    Acetylation of α-Tubulin by Aspirin and Histone Deacetylase 6 in Human Platelets

    A.M. Latorre1, S. Bonanad2, A. Moscardo2

  • Abstract Number: PB1177

    Achenbach Syndrome in a 19 Year-Old Girl: A Clinical Case

    D.O.W. Rodrigues1, N.N.S. Magalhaes2, O.F. Santos3, L.O.W. Rodrigues4

  • Abstract Number: PB1335

    Achieving Clinically Relevant Platelet Count Response Thresholds with Avatrombopag (AVA) in Immune Thrombocytopenia (ITP)

    I. Altomare1, M. Vredenburg2, W. Tian2, K. Aggarwal2

  • Abstract Number: PB0475

    Acquired Antithrombin III Deficiency Is a Risk Factor for Venous Thromboembolism after Severe Injury

    E. Rahbar1, B. Cotton2, C. Wade2, J. Cardenas2

  • Abstract Number: PB0773

    Acquired Deficiency of Dependent Coagulation Factors of Vitamin K, at the Teaching Center: Experience In 10 Years

    J. Daza1,2, C. Casas1,2, M.H. Solano1,2

  • Abstract Number: PB1701

    Acquired GPVI Deficiency Is a Biomarker for Early Diagnosis and Prognostic Assessment of Patients with Sepsis

    L.J. Weiss1, G. Manukjan1, N. Nagler2, M. Kredel3, T.-T. Lâm4, B. Nieswandt1,5, D. Weismann2, H. Schulze1

  • Abstract Number: PB0162

    Acquired Haemophilia Spanish Registry, First Five Years of Activity

    M.E. Mingot-Castellano1,2, J.M. Bastida-Bermejo3, S. Haya4, J. Pardos-Gea5, M.D.C. Fernandez-Sanchez de Mora6, R. Lluch7, R. Nuñez8, M.T. Alvarez-Roman9, I. Soto-Ortega10, J.M. Martín-Antoran11, J.A. Rodriguez-Garcia12, M. Carrasco-Exposito13, J.A. Rodriguez-Alen14, C. Cervero-Santiago15, M. Perez-Sanchez16, R. Rodriguez-Gonzalez17, N. Fernandez-Mosteirin18, M.N. Alonso-Escobar19, A. Moreto-Quintana20, P. Marco-Vera21, Registro Español de Hemofilia Adquirida

  • Abstract Number: PB0795

    Acquired Hemophilia A in Young Nulliparous Woman: A Case Report

    E. You

  • Abstract Number: PB0780

    Acquired Hemophilia in Argentina: A Multicentric Study

    F. Chuliber1, A. Sanchez Luceros2, M.L. Romero2, C. Duboscq3, M. Martinuzzo4, L. Beligoy5, M. Clavijo6, A. Pintos Marquez7, S. Garbiero8, M. Arias9, M.D.C. Gallo10, M. Del Castillo11, A. Bonacina12, D. Villalba13, A. Juarez Avignone14, J. Jerez15, V. Castoldi16, A. Lo Turco17, A. Baques9, D. Penchasky4

  • Abstract Number: PB1882

    Acquired Thrombotic Thrombocytopenic Purpura: Key Findings of Patients from Southern Italy

    G.L. Tiscia1, F. Cappucci1, L. Fischetti1, C. Battista2, A. Ostuni2, G. Giordano3, G. Tarantini4, T.M. Santeramo4, G. Giuffrida5, D. Nicolosi5, P.R. Scalzulli6, N. Cascavilla6, L. di Mauro7, E. Grandone1

  • Abstract Number: PB2295

    Acquired Type II (IIb) Protein S Deficiency, Case Report

    T. Fenclova1, V. Geierova2, M. Zemanova1, P. Salaj2, I. Hrachovinova1

  • Abstract Number: PB1583

    Acquired von-Willebrand-Disease (aVWD) in ECMO Patients: a 3-Year Cohort Study

    T. Bajorat1, B. Panholzer2, A. Haneya2, D. Kowalski1, D. Juhl3, A. Rocke1, M. Shneyder1, P.M. Kuta1, H. Clausnizer1, U. Nowak-Göttl1

  • Abstract Number: PB1785

    Activated Factor XI Promotes Complement Activation by Neutralizing Complement Factor H

    C. Puy1, R.S. Keshari2, C. Lorentz1, E. Tucker1, J. Morrissey3, S. Smith3, D. Gailani4, A. Gruber1, F. Lupu2, O. McCarty1

  • Abstract Number: OC 06.4

    Activated Protein C Reverses the p21-Mediated Hyperglycemic Memory in Diabetic Nephropathy

    A. Elwakiel1, M.M. Al-Dabet1, K. Shahzad1, A. Sulaj2, C. Dockendorff3, R. Geffers4, J. Griffin5, S. Kohli1, B. Isermann1

  • Abstract Number: PB0381

    Activated Protein-C up Regulates Microparticles Release from Ovarian Cancer Cell Line

    S. Besbes1, R. Attal1, S. Mirshahi1,2, M. Pocard1, J. Soria1, M. Mirshahi1

  • Abstract Number: PB1111

    Activated Prothrombin Complex Concentrates for the Management of Direct Oral Anticoagulant-Associated Bleeding Events and Pre-Operative Administration for Urgent Surgery: Hemostatic and Thrombotic Outcomes

    J. Shaw1, M. Carrier1, D. Dowlatshahi2, S. Chakraborty3, M. Tokessy4, H. Buyukdere4, L. Castellucci1

  • Abstract Number: PB0154

    Activated recombinant Factor VII (rFVIIa) Inhibitor in Iran: Immunogenicity is a Major Challenge through Treated Bleeds Covered with rFVIIa

    P. Eshghi1, M. Ahmadinejad2, M. Karimi3

  • Abstract Number: PB0249

    Activation of Coagulation by 5.8S RNA

    A. Alharbi, R. Raman, N. Iyer, A. Al Qaryoute, D. Burks, R. Azad, P. Jagadeeswaran

  • Abstract Number: PB2013

    Activation of ERK Signaling Pathway by Plasma IgG in Venous Thromboembolism Patients without Antiphospholipid Antibodies

    S. Bouvier1,2,3, S. Bastide4, M. Fortier1, J. Laurent5, E. Mercier1,2,3, E. Nouvellon1, A. Remy1, G. Lavigne1, I. Quéré6, A. Pérez-Martin2,5, J.-C. Gris1,2,3

  • Abstract Number: PB0462

    Active Thrombin and its Value: New Approach to Diagnosis of Thrombosis?

    J. Stikarova, J. Dyr

  • Abstract Number: PB1103

    Activity Measurement of Factor IX Padua against the 4th International Standard for FIX, Plasma

    E. Gray1, A. Riddell2, J. Foley3, D. Verhoef3, R. Corbau3, A. Nathwani2,3

  • Abstract Number: PB0394

    Acute Deep Vein Thrombosis Is Associated with Increased Platelet Thrombin Generation and Increased Procoagulant Oxidised Phosphatidylethanolamine

    S.G. Obaji1, D.A. Slatter2, V.J. Tyrrell2, P.V. Jenkins1, V.B. O'Donnell2, P.W. Collins1

  • Abstract Number: PB1820

    Acute Exacerbations of COPD Induce a Prothrombotic State through Platelet-Monocyte Complexes, Endothelial Activation and Increased Thrombin Generation

    L.N. van der Vorm1,2,3, L. Li2,3, D. Huskens2,3, J. Hulstein1, M. Roest2,3, P.G. de Groot3, H. ten Cate3, B. de Laat2,3, J. Remijn1,3,4, S. Simons5,6

  • Abstract Number: PB0113

    Acute Leriche Syndrome in a 55-Year-Old Woman with Recurrent Central Pulmonary Embolism: A Case Report

    V. Muster1, P. Jud1, K. Gütl1, M. Tomka2, A. Baumann2, M. Anelli-Monti3, P. Srekl-Filzmaier3, R.H. Portugaller4, M. Brodmann1, T. Gary1

  • Abstract Number: PB0360

    ADAMTS-13/VWF as Biomarker for Portal Vein Thrombosis Development in Cirrhotic Patients: A Prospective Study

    M. Sacco1, S. Lancellotti2, A. De Magistris3, M. Tardugno4, M. Basso2, M. Pompili4,5, R. De Cristofaro4,6

  • Abstract Number: OC 07.2

    ADAMTS13 Conformation Is Closed in Acquired Thrombotic Thrombocytopenic Purpura in the Absence of Anti-ADAMTS13 Autoantibodies

    E. Roose1, B.S. Joly2,3, A.-S. Schelpe1, I. Pareyn1, A. Vandenbulcke1, C. Tersteeg1, S.F. De Meyer1, P. Coppo4, A. Veyradier2,3, K. Vanhoorelbeke1

  • Abstract Number: PB1429

    Addition of Exogenous Platelet Factor 4 in the Heparin Induced Platelet Activation (HIPA) Assay for the Detection of Pathogenic Heparin-induced Thrombocytopenia Antibodies

    D. Faille, M.-C. Bourrienne, N. Ajzenberg

  • Abstract Number: PB0227

    Addition of Histone Deacetylase Inhibitors Increases Recombinant Factor V Expression in BHK Cells

    T. Petrillo1, J.C. Small1, R.M. Camire1,2

  • Abstract Number: PB1093

    Adenovirus Mediates Expression of Human Coagulation Factor IX Gene in Adipose-Derived Mesenchymal Stem Cells

    Z.Y. Yan1, X. Wang2, J. Li3, Y. Xie3, L. Wang3, Y. Zhu3, H. He3, Q. Sun3

  • Abstract Number: PB0368

    Adhesive Properties of Plasma-Circulating and Platelet-Derived Microvesicles

    E. Artemenko1,2, D. Nechipurenko1,2,3, S. Obydennyi1,2, M. Panteleev1,2,3

  • Abstract Number: PB0479

    Administration of Fibrinogen vs. Cryoprecipitate Stored out to 10 Days in Microfluidic Models of Coagulopathies in Hemorrhage

    S.M. Shea, K.A. Thomas, P.C. Spinella

  • Abstract Number: PB1570

    Adolescent Menorrhagia and Von Willebrand Disease

    Y. Ouarhlent, M.R. Makhloufi

  • Abstract Number: PB0787

    Advanced Principles of Prevention and Treatment of Preeclampsia in Women with Antiphospholipid Syndrome (APS) and MTHFR C677T Mutation

    M. Jangidze1, N. Kintraia2, P. Zhorzholiani3, T. Saralidze4, N. Metskhvarishvili2, M. Rizvadze2

  • Abstract Number: PB0687

    Advancing the Understanding and Significance of Genetic Testing Results in Hemostasis/Thrombosis

    K. Lee1, D. DeMille2, K. Gomez3,4, W. Kahr5, M. Lambert6, D. Lillicrap7, D. McDougal1, S. Mohan1, P. Morange8, A. Mumford9, J. Ross1, J. Zehnder10, J. Berg1, N. Key11, on Behalf of the ClinGen Hemostasis/Thrombosis Clinical Domain Working Group Executive Committee

  • Abstract Number: PB0962

    Adverse Event Reporting in Haemophilia A Patients with and without Inhibitors Treated with Emicizumab: A Report from the Co-morbidity Working Party of the UK Haemophilia Centres Doctors´ Organisation (UKHCDO)

    C. Wall1, G. Hall2, P. Collins3, M. Makris4, S. Shapiro5, R. Liesner6, C. Harrison4, R. Maclean4, S. Mangles7, G. Benson8, G. Evans9, P. Sartain10, C. Hay11, UK National Haemophilia Database

  • Abstract Number: PB2189

    Afibrinogenemia and Leiden FV Within the Same Family

    S. Hadjali-Saichi1, K. Guenounou-Guemmour1, D. Helley-Russick2, P. De Mazancourt3, I. Frigaa1

  • Abstract Number: PB1199

    Afibrinogenemia: Identification of a New Mutation in FGB

    E. Chinni1, G.L. Tiscia1, G. Favuzzi1, B. Bruschi2, P. Coccia2, I. D'Alba2, S. Gobbi2, V. Petroni2, P. Pierani2, F. Cappucci1, L. Fischetti1, P. Vergura1, G. Vecchione1, A. De Laurenzo1, D. Colaizzo1, E. Grandone1

  • Abstract Number: PB0083

    African American Women with Diabetes Undergoing Catheterization Represent Most Prothrombotic Subgroup: An Explanation for the Platinum Diversity Study Results?

    U. Tantry1, K. Bliden1, R. Chaudhary2, P. Gurbel3

  • Abstract Number: PB2015

    Ageing Affects Neutrophils – Changes in Activation, DNA Release and Neutrophil Extracellular Formation of Neutrophil Subpopulations with Human Age

    L.-M. Mauracher1, M. Krall1, J. Roiß1, L. Hell1, A.S. Ondracek2, J. Gebhart1, C. Brostjan3, C. Ay1, I. Pabinger1

  • Abstract Number: PB0703

    Algorithm for Detection of Procoagulant Samples with Elevated Prothrombin and Reduced Antithrombin by their Ability to Deplete Fluorogenic Thrombin Substrate

    W. Chang1, K. Machlus2, A. Wolberg2, M. Ovanesov1

  • Abstract Number: PB0241

    Allosteric Modulation of Exosite 1 Attenuates the Enhancing Effect of Polyphosphate on FXI Activation by Thrombin

    R. Yin1,2, V. Patel1,2, E. Ajewole1, J. Fredenburgh1,3, J. Weitz1,3

  • Abstract Number: PB2012

    Altered Coagulation Parameters and D-Dimer Measurements in Sepsis Are Useful in Scoring the Risk Stratification

    D. Joshi1, E. Bontekoe1, M. Rondina2, E. Middleton2, A. Blair2, F. Siddiqui1, D. Hoppensteadt1, J. Fareed1

  • Abstract Number: PB0668

    Altered FIBTEM/Fibrinogen Correlation in Liver Transplant Patients Relative to Cardiac Surgery Patients

    E. Salazar1, S. Lindberg2, C. Leveque1, B. Castillo1, J. Chen1

  • Abstract Number: PB2532

    Alternative Complement Pathway Activation in the Severe Hypertensive Disorders of Pregnancy

    R. Neki1,2, T. Miyata3, K. Ohtani4, Y. Hidaka5, K. Ida1, T. Yokouchi-Konishi2, A. Nakanishi2, J. Yoshimatsu2, K. Kokame6, N. Wakamiya7, N. Inoue5

  • Abstract Number: PB0239

    Always Ask Relevant Questions to Patients Might Be They Tell You the Diagnosis

    A. Naz1, T. Masood2, N. Saqlain3, N. Samad4, T. Shamsi5

  • Abstract Number: PB2097

    Amelioration of the Pathologic Changes in the Hepatocyte-Specific BRAFV600E Mutated Mice by Administration of Aspirin

    H. Tanaka1, K. Horioka2, K. Yamazaki3, K. Ogawa4

  • Abstract Number: PB1700

    An Activation-dependent Pathway Modulated by Dicer1 Neosynthesis and Down-regulating Platelet Reactivity Is Impaired in Diabetes

    E. Piselli1, L. Bury1, G. Manni1, S. Momi1, C. Fanelli2, G. Perriello2, P. Gresele1

  • Abstract Number: PB1729

    An Artificial Lipid Membrane Platform as an Approach to Study CLEC-2 Receptor Clustering

    M.A. Sowa1,2, Y. Di3, S.P. Watson3, J.M. Gibbins1, Á. García2, A.Y. Pollitt1

  • Abstract Number: PB2270

    An Assessment of the Cost-Effectiveness of Whole-Leg Ultrasound Scans Compared to Proximal Leg Vein Ultrasound Scans in the Diagnosis of Acute Deep Vein Thrombosis

    G. Bertone1, Z. Lester2, H. Rowswell2, T. Nokes2, W. Thomas2

  • Abstract Number: PB2379

    An Audit Examining Information Provided to Patients Regarding Venous Thromboembolism (VTE) at Discharge

    K. Karia, S. Parikh, G. Lowe

  • Abstract Number: PB0481

    An Audit of Fresh Frozen Plasma Transfusions: Justified or Not?

    A. Memon1, F. Qaisar2

  • Abstract Number: PB1635

    An Elevated Platelet Count Increases the Rate of Prothrombin Activation, but Not the Total Amount of Thrombin Formed

    Q. Yan1,2, M. Ninivaggi1, B. de Laat1, R. de Laat-Kremers1

  • Abstract Number: PB0614

    An Evaluation of the Assay Performance of the Antifactor Xa Assay for Rivaroxaban

    V. Prasad, H.J. Yeo, S. Abdul Latiff, M.S. Wong

  • Abstract Number: PB2469

    An Evaluation of the Basis for Anti-Xa Testing in Patients on Low Molecular Weight Heparin and its Impact on Subsequent Management

    S.H. Yeang1, W.M. Tan1, E.Y. Kuo1, Y.T. Shim1, W.S.J. Loke2, W.H. Wong2, M.A. Cheong2, C.W. Tan2, H.J. Ng2

  • Abstract Number: PB0626

    An Evaluation of Treatment Monitoring in Patients with VWD Using a Chemiluminescent (VWF:GP1bR) Assay Compared to a Lyophilised Platelet Assay with Ristocetin (VWF:RCo)

    A. Riddell1, L. Lanning1, S. Vinayagam1, T.T. Yee2, P. Chowdary2

  • Abstract Number: PB0556

    An Improved Algorithm for the Detection of Lipemia as Interfering Substances on a Fully Automated Coagulation Analyzer

    K. Sass1, J. Kramer2, O. Bätz2, S. Echternacht1, S. Crombach3

  • Abstract Number: OC 09.3

    An Insight into Clinical Outcomes in Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study

    F. Nissen1, T. Burke2, S. Asghar2, E. Ferri Grazzi2, A. Shang1, F. Castro1, M. Aizenas1, O. Meier1, J. O'Hara2,3

  • Abstract Number: OC 09.2

    An International Multicenter Study of Bevacizumab for Bleeding in Hereditary Hemorrhagic Telangiectasia (The InHIBIT-Bleed Study)

    H. Al-Samkari1,2, R. Kasthuri3, J. Parambil4, H. Albitar5, Y. Almodallal6, C. Vazquez7, M. Serra7, S. Dupuis-Girod8, C. Wilsen9, J. McWilliams9, E. Fountain10, J. Gossage10, C. Weiss11, M. Latif11, A. Issachar12, M. Mei-Zahav13, M. Meek14, M. Conrad15, D. Kuter1,2, V. Iyer16

  • Abstract Number: PB0582

    An International Study on the Interpretation of Test Results of the APTT Mixing Test

    P. Meijer1, J.M. Bauça2, É. Ajzner3, A. Hillarp4, A.H. Kristoffersen5,6, Working Group on the Postanalytical Phase (EFLM / EQALM)

  • Abstract Number: PB1206

    An Italian Survey on the Real-world Use of rFXIII (Catridecacog) in Patients with Factor XIII Deficiency

    E. Zanon1, S. Pasca1, G. Sottilotta2, A.C. Molinari3, L. Banov3, A. Ferretti4, P. Di Gregorio5, B. Pollio6, S.M. Siboni7, R. Palla7, L. Spiezia8, M. Pizzuti9, L.D. Notarangelo10, P. Simioni11

  • Abstract Number: PB2086

    An observational Study of INR Control and Bleeding Events, According to European Society of Cardiology (ESC) Guidelines, in Non-valvular Atrial Fibrillation (NVAF) Stratified by Male and Female Sex

    D. Harris1, F. Torabi1, R. Alikan2, A. Akbari1, D. Mallory1, D. Thayer1, T. Wang1, S. Grundy3, S. Lister4, M. Gravenor1, J. Halcox1

  • Abstract Number: PB0343

    An Overview of Patients with Hemophilia A in China: Epidemiology, Disease Severity, and Treatment Strategies

    X. Song1, J. Zhong2, F. Xue1, L. Chen1, H. Li1, D. Yuan1, J. Xie2, J. Shi1, L. Zhang1, E.Q. Wu2, R. Yang1, Analysis Group, Inc., Beijing, China

  • Abstract Number: PB1947

    An Unusual Case of Cerebral Cavernous Malformation Complicated with Consumptive Coagulopathy and Heightened Fibrinolysis

    M.-C. Shen1, C.-Y. Lin1, W.-L. Chen2, Y.-H. Shih1, Y.-C. Huang3

  • Abstract Number: PB0457

    Analysis of Biomarkers of Hemostatic Dysregulation and Inflammation in Lymphoma Patients

    D. Antic1, V. Otasevic1, E. Bontekoe2, F. Siddiqui2, D. Hoppensteadt2, N. Baig2, J. Sinacore2, V. Djurasinovic1, V. Vukovic1, K. Tomic1, B. Mihaljevic1, J. Fareed2

  • Abstract Number: PB2300

    Analysis of Hemodynamic and Hemocoagulation Changes in Mortality Structure in Polytrauma Patients

    Y. Volkova, N. Baranova

  • Abstract Number: PB0550

    Analysis of Megathrombocytes as a New, Fast, and Low Cost Tool to Indicate Thrombosis and Predict Prognosis in Sickle Cell Disease

    L.W. Serrao1, E.F.N. Silva Lisboa2, P.F. Rosa de Siqueira3, M.C. Canellas da Silva1, J. Medeiros4, A. Soares5, M.K. Fleury1

  • Abstract Number: PB2443

    Analysis of Outcomes Following Inferior Vena Cava (IVC) Filter Placement in a Single Center Population

    C. Enciso1, N. Torres2, J.M. Freue1, J. Scapellato2, R.M. Campestri1

  • Abstract Number: PB0778

    Analysis of Patients with Diagnosis of Adquired Haemophilia in a Third Level Hospital

    A. Gómez Martínez1, M. Villalba Montaner2, E. Salvador Rupérez1, A. García Ortego1, S. Pinzón Mariño1, S. Martín-Consuegra Ramos1, C.F. Hernández Mata1, M. Moreno Carbonell1, E. González Gómez1, J.M. Calvo Villas1, N. Fernández Mosteirín1, P. Delgado Beltrán1

  • Abstract Number: PB0630

    Analysis of Platelet Functional Activity by Flow Cytometry: Reference Intervals and Cut-off Value for Evaluating the Efficiency of Antiplatelet Therapy

    A. Ermakov1,2, L. Gaykovaya1,2, O. Sirotkina1,3, T. Vavilova1

  • Abstract Number: PB2505

    Analysis of Population Values in Pregnant Women

    M.L. Iglesias Varela1, M. Siracusa1, M. Paz1, D. Jacobsen1, N. Salguero2, L. Maggi1

  • Abstract Number: PB0573

    Analytical Performance Validation of the T-TAS 01 PL Assay

    J. Dahlen1, K. Dobashi2, W. Yuan2, S. Ishikawa2, K. Hosokawa2

  • Abstract Number: PB0638

    Analytical Validation of a Novel Whole Blood Coagulometer for NOAC Testing

    S. Bakhru1, X. Jiang1, L. Chen1, Y. Wang1, D. Osmani1, D. Mootoo1, J. Ansell2, S. Zappe1

  • Abstract Number: PB0348

    Analytical Variability (CV) of One Stage Factor VIII Assay: A Quality Control (QC) Experience. Argentinian Group of Biochemists in Hemophilia

    M.D.V. Arias1, E. Sueldo1, G. Detarsio2

  • Abstract Number: PB0616

    Analytical Verification of Automated Latex-Enhanced Particle Immunoturbidimetric D-Dimer Assays on Diferent Analytical Platforms and Comparability of Test Results

    I. Lapić1, S. Prpić2, A. Prce3, D. Coen Herak1, R. Zadro1,4, D. Rogić1,4

  • Abstract Number: PB1431

    Anaphylactic Shock to Apixaban in a Patient Treated for Heparin-induced Thrombocytopenia (HIT)

    M. Afonso1, A.G. Lopes2, R. Cardoso Araújo3, M. Vasconcelos3, A.P. Barbosa1, A. Marques1

  • Abstract Number: PB1119

    Andexanet and Prothrombin Complex Concentrate Give Comparable Haemostatic Efficacy for Major Bleeding in Patients on Factor Xa Inhibitors

    T.C.C. Jaspers1, K.N. Shudofsky2, M.V. Huisman3, K. Meijer4, N. Khorsand5

  • Abstract Number: PB0839

    Animal Model Construction for Hemophilic Arthritis: Evaluation of Hemophilia Joint by Ultrasound Detection

    H. Liu1, C. Xu1, Y. Li1, J. Sun2, F. Ma1, Y. Zhang1, Y. Gao1, M. Yi1, Z. Xu1

  • Abstract Number: PB0124

    Anti-Aggregant Effect of Butanolic Extract of Rubia Tinctorum on Platelets in vitro and ex vivo

    F.Z. Marhoume1, Y. Zaid2, A. Alioua3, A. Chait4, A. Bagri1

  • Abstract Number: PB1784

    Anti-complement Effect of Heparin in Stimulated Whole Blood

    J. Hogwood1, Y. Qiao2, S. Pitchford2, C. Page2, B. Mulloy2, E. Gray1,2

  • Abstract Number: PB0226

    Anti-factor V Inhibitor after Liver Transplantation

    A. Ciavarella1, A. Artoni1, M. Capecchi1, S. Bhoori2, V. Mazzaferro2, C. Novembrino1, A. Cairo1, M. Clerici1, C. Valsecchi3, F. Peyvandi1, I. Martinelli1

  • Abstract Number: PB1796

    Anti-Platelet Drug Ticagrelor Has a Direct Anticancer Activity

    O. Elaskalani1, P. Metharom1,2

  • Abstract Number: PB1919

    Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies Cause Lupus Anticoagulant by Interfering with Factor Xa-Mediated Factor V Activation

    T. Noordermeer1, J.E. Molhoek2, S.A.E. Sebastian2, S. Drost-Verhoef2, A.C.W. van Wesel2, P.G. de Groot3, J.C.M. Meijers4,5, R.T. Urbanus1

  • Abstract Number: PB0104

    Antiaggregation Evaluation of Aspirin and Clopidogrel in Endovascular Treatment of Intracranial Aneurysms with Flow Diverter Stents

    A. Moscardo1, F. Aparici2, F. Ferrando1, A. Blanquer1, A.M. Latorre3, P. Bosch3, S. Bonanad1

  • Abstract Number: PB1637

    Antibodies Protect Platelets against Streptococcus Pneumoniae Toxin Pneumolysin

    S. Handtke1, K. Jahn2, R. Palankar3, T.P. Kohler2, S. Hammerschmidt2, A. Greinacher1

  • Abstract Number: PB0424

    Anticoagulant Activity in Unclassified Bleeding Disorders

    D. White1, S. MacDonald1, J. Langdown1, K. Downes2,3, W. Thomas1

  • Abstract Number: PB0213

    Anticoagulant Effect of Novel Nanoparticles Functionalized with Synthetic Piperazinone Derivatives as FXa Inhibitors

    J. Salazar1,2, C. Rojas2, F. Santana-Romo2, A. Romero Bohorquez3, C. Vilos4, F. Zacconi2,5

  • Abstract Number: PB0182

    Anticoagulant Effects of Parenteral Sulodexide as Measured by Activated Clotting Time. Relevance to Dosing in Various Indications

    B. Daravath1, J. Fareed1, O. Iqbal1, A. Kouta1, D. Hoppensteadt1, W. Jeske1, F. Siddiqui1, M. Lewis1, B. Lewis2

  • Abstract Number: PB2074

    Anticoagulant Management Strategies in Cancer Patients with Atrial Fibrillation in Daily Clinical Practice

    G. Chu1, M.V. Huisman1, H. Gelderblom2, M.E. Hemels3,4, T. van der Hulle2, S.A. Trines5, F.A. Klok1

  • Abstract Number: PB2442

    Anticoagulant Therapy for Splanchnic Vein Thrombosis in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis

    E. Valeriani1, M. Di Nisio2, N. Riva3, O. Cohen4,5, E. Porreca1, M. Senzolo6, A. De Gottardi7, M. Magaz8, J.-C. Garcia-Pagan8, W. Ageno9

  • Abstract Number: PB2254

    Anticoagulant Therapy for Splanchnic Vein Thrombosis: A Systematic Review and Meta-Analysis

    E. Valeriani1, M. Di Nisio2, N. Riva3, O. Cohen4,5, J.-C. Garcia-Pagan6, M. Magaz6, E. Porreca1, W. Ageno7

  • Abstract Number: PB2460

    Anticoagulation Control with the Point-of-Care INR: A Retrospective Pre-/Post-analysis

    N. Riva1, S. Meli2, C. Borg Xuereb3, W. Ageno4, M. Makris5, A. Gatt1

  • Abstract Number: PB2517

    Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Survey

    I. Malhame1, M. Othman2,3, P. Casais4,5, R. D'Souza6, R. Wald7,8, C.K. Silversides7,8, M. Sermer6, N. Shehata9,10

  • Abstract Number: PB2445

    Anticoagulation in Cirrhosis: Thrombin Generation Assay vs Anti FXa Activity

    S. Pons1,2, M.D.L. Herrera1,2, A. Grinspon1, A. Scazziota1,2

  • Abstract Number: PB2055

    Anticoagulation in Non-Valvular Atrial Fibrillation: Old or New Friends?

    M.-A. Gaman1, E.-C. Dobrica2, M.-A. Cozma2, C.C. Diaconu3

  • Abstract Number: PB2069

    Anticoagulation Resumption After Intracerebral Hemorrhage in Two Cohorts of Patients Treated with Vitamin K Antagonists and Direct Oral Anticoagulants

    D. Poli1, E. Antonucci2, E. Vignini1, L. Martinese1, S. Testa3, G. Guazzaloca4, P. Simioni5, V. Pengo5, P. Pignatelli6, A. Falanga7, L. Masciocco8, D. Barcellona9, A. Ciampa10, P. Chiarugi11, C. Paparo12, E. Bucherini13, M. Marzolo14, W. Ageno15, G. Palareti2

  • Abstract Number: PB2154

    Anticoagulation Therapy as Prevention of Cancer Relapce

    A. Vorobev, A. Makatsariya, V. Bitsadze, J. Khizroeva, A. Solopova, V. Sannikova, S. Petrova

  • Abstract Number: PB2159

    Anticoagulation Therapy Management in Oncological Patients: Experience in a Center

    A. Pimentel Feliciano, A. Ortiz López, M. Dobón Rebollo, L. Palomera Bernal, O. Gavín Sebastián

  • Abstract Number: PB0166

    Anticoagulation with the Novel, Small-molecule Factor XIa (fXIa) Antagonist, EP-7041, Prevents Oxygenator Clotting but Conserves Hemostasis in a Canine Extracorporeal Circulation (ECMO) Model

    M.A. Kurz1, C.V. Pollack, Jr.1, J.M. Connors2, J.H. Levy3, C. Drummond4, D. Klein5, H.D. Josuns5, R. Pielemeier4, J. Buchino4, P. Osborne4, N.J. Hayward1

  • Abstract Number: PB0571

    Antifactor Xa Levels vs. Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin

    V.M. Silva1, C. Cavalheiro2, C.C. Strunz3

  • Abstract Number: PB2168

    Antimetastatic Profile of Bovine Intestinal Heparin and its Low Anticoagulant Activity Derivative

    M. Sá Pereira1,2, K.V. Micheli1, C.R. Fernades1, A.C.E.S. Vilela-Silva2,3, A.G.F. Lima4, A.L. Guedes1, F.F. Ferreira5, A.M.F. Tovar1,2, M.S.G. Pavão1,2, P.A.S. Mourão1,2

  • Abstract Number: PB1377

    Antimicrobial Prophylaxis in Patients with Immune Thrombocytopenia Treated with Rituximab: A Retrospective Multicenter Analysis

    S. Raso1, M. Napolitano2, G. Arrigo1, F. Reale1, P. Silimbiani3, A. Lucchesi4, A. Maggio5, G. Calvaruso5, U. Consoli6, M.F. Mansueto1, S. Siragusa2

  • Abstract Number: PB0029

    Antioxidant Defense Gene Polymorphism in the Nenets Population

    N. Vorobyeva1, N. Belova2, A. Vorobyeva2, S. Nemanova1

  • Abstract Number: PB1911

    Antiphospholipid Antibodies “Multi-Positivity” in Women with Thromboembolism

    J. Khizroeva, V. Bitsadze, N. Makatsariya, M. Arslanbekova, K. Sultangadzhieva, A. Vorobev, I. Khamani, N. Babaeva, A. Antonova

  • Abstract Number: PB0011

    Antiphospholipid Antibodies in Acute Myocardial Infarction

    Y. Zhang, X. Wang, Z. Yu, Z. Zhou

  • Abstract Number: PB2022

    Antisense Oligonucleotide Targeting of Thrombopoietin Represents A Novel Platelet Depletion Method to Assess the Role of Platelets During Inflammation Resolution

    T. Barrett1, B. Wu1, A. Revenko2, A.R. Macleod2, L. Segal1, J. Berger1

  • Abstract Number: PB1312

    Antithrombin Activity Level below 60% in Children Has Implications for Heparin (LMWH) Dosing

    I. Regan1, C. Pillion2, M. Riordan3, B. Nolan1

  • Abstract Number: PB2450

    Antithrombin III Levels Immediately Following Acute Venous Thromboembolism

    C. Kabrhel1,2, R. Rosovsky3,4, N. Giordano1, H. Zheng5

  • Abstract Number: PB0179

    Antithrombotic Effects of a Novel Small Molecular Fxia Inhibitor BMS-986177/JNJ-70033093 in a Rabbit AV-Shunt Model of Thrombosis

    X. Wang, Q. Li, F. Du, N. Shukla, A. Nawrocki, M. Chintala

  • Abstract Number: PB2367

    Antithrombotic Offices of the Arkhangelsk Region Russia

    N. Vorobyeva1, A. Vorobyeva2

  • Abstract Number: PB0144

    Antithrombotic Properties of Carvedilol Shown in Two Independent Intravital Real Time Models of Thrombosis

    P. Czajkowski1, D. Jarmoc2, T. Rusak2, K. Kramkowski2

  • Abstract Number: PB2452

    Antithrombotic Stewardship: A Novel Approach to Appropriate Anticoagulant Prescription

    M. Koolian1,2, R. Kerzner3, N. Kampouris3, H. Mantzanis3, S.R. Kahn1,2,4

  • Abstract Number: PB2543

    Antithrombotic Therapy (Nadroparin Calcium) in the Prevention of Pregnancy Loss in aPL-Positive Women

    V. Bitsadze1, J. Khizroeva1, E. Orudzhova2, A. Shkoda2, E. Bayanduryan3, M. Novosartyan3, A. Makatsariya1

  • Abstract Number: PB1469

    Antithrombotic Therapy by Charged Nanoparticles

    M. Griffin1, K. Ashworth2, J. Di Paola2, D. Ku1

  • Abstract Number: PB2535

    Antithrombotic Therapy for Pregnant Woman with Bland-White-Garland Syndrome and Prosthetic Mitral Valves

    M. Arslanbekova, A. Makatsariya, J. Khizroeva, V. Bitsadze, K. Sultangadzhieva, N. Babaeva

  • Abstract Number: PB1327

    Antithyroid Treatment Improves Thrombocytopenia in a Young Patient with Graves´ Disease: A Case Report

    V.V. Palmieri, G. Lassandro, A. Amoruso, V. Palladino, C. Pastore, P. Giordano

  • Abstract Number: PB1965

    Aortic Ring Angiogenesis Proceeds Normally Despite Minimal Tissue Factor Expression

    J. Xu1, L. Sommerville1, N. Mackman2, M. Hoffman1,3

  • Abstract Number: PB0853

    APC: A New Suspect in the Hunt for a Mechanism of Bone Disease in Hemophilia

    G. Goldscheitter1,2, J.A. Taylor1,2, R.F. Klein1,2

  • Abstract Number: PB2140

    Apixaban Levels In Cancer-Associated Thrombosis In Low-Weight Individuals

    V. Bravo-Villa1, J. Romero2, E. Rojas-Saldivar2, R. Villa2, M. Cervantes-Alarcón2, P. Baz2, G. Cesarman Maus2

  • Abstract Number: PB0606

    Apixaban Plasma Concentration Estimation by Anti Xa Activity Assay Calibrated with Heparin Calibrators with 2 Different Reagent/Systems

    M.M. Martinuzzo1,2, E. Sueldo3, M.S. López2,4, C. Duboscq5, E.S. Viñuales6,7, D. Mezzarobba8, J. Ceresetto5, L.H. Barrera9,10, M. Arias3, M. Gurfinkiel11, J. Oyhamburu7,9

  • Abstract Number: PB2399

    Apixaban versus Heparin/Warfarin Treatment in Pulmonary Embolism: Results from the UK Apixaban Length-of-Stay Pulmonary Embolism – Hospital Admissions Study (ALPHA-PE)

    R. Alikhan1, C. Church2, S. Shapiro3, S. Lister4, S. Chattree5, N. Smith6, C. Bomken7, S. Grundy4, J. Gordon8, D. Sugrue8, N. Hill4, L. Howard9

  • Abstract Number: PB0361

    APML: 2 Cases of Discordant Coagulation Results and ROTEM Testing

    A. Chee, K. Lewis, B. Conway, R. Howman, C. Grove

  • Abstract Number: PB2346

    Apo(a) Polymorphisms rs3798220 and rs10455872 in a Brazilian Population of Deep Venous Thrombosis Pacients

    I. Macedo Toni1, M. Carmen Goncalves Lopes Fernandes1, A. Lamônica1, S.A. de Lima Montalvão1, J.M. Annichino Bizzacchi1,2

  • Abstract Number: PB0072

    Apolipoprotein A-IV Is an Endogenous Inhibitor of Thrombosis: The Roles of Polymorphisms in the Risk of Cardiovascular Disease

    S.-Y. *Yu1,2, D. *MacKeigan1,3, M. Neves1,3,4, P. Chen1,4, H. Ni1,3,4

  • Abstract Number: PB0483

    Apoptosis Inhibition during Cold Storage of Apheresis Platelet Concentrates Improves Cell Vitality without Affecting the Functionality

    I. Marini1, Y. Tamamushi1, L. Pelzl1, K. Althaus1,2, S. Nowak-Harnau2, T. Bakchoul1,2

  • Abstract Number: PB1328

    Apoptotic Markers May Help in Predicting the Disease Course of Pediatric Immune Thrombocytopenic Patients

    S. Levy Mendelovich1, S. Aviner2, N. Sharon3, H. Miskin4, J. Yacobovich5, G. Kenet1, H. Hauschner6, N. Rosenberg1

  • Abstract Number: PB0585

    Application of EP15A3 and EP15A2 Protocols to Verify the Performance of a Coagulometer in the Coagulation Laboratory of the National Institute of Respiratory Diseases in Mexico City

    B.S. Zuñiga Ascencio1, F. Vidal Martinez2, M. J. Castillejos López, B. A. Lira Mendoza, M. E. Jaime Capetillo, E. Juárez Silva, Ma. A. Rodríguez Ventura, R. Guevara Gutiérrez

  • Abstract Number: PB1257

    Application of the First Russian Biosimilar of Recombinant Clotting Factor VII in an Infant with Antenatal Cryptogenic Hepatitis and Bleeding Developed After Laparosopic Liver Biopsy

    K. Papayan1, L. Zhukova1, I. Myznikova1, A. Syrtsova1, E. Kuchina1, A. Taukov1, E. Trizna1, A. Yakovlev1, A. Podkamenev1, D. Kudlay2, N. Nemstsveridze1

  • Abstract Number: PB2524

    Approach to Venous Thromboembolism Risk in Women with Physical Disability in Pregnancy – Multidisciplinary Survey

    S. Kazi1, A. McLeod2, A. Berndl3

  • Abstract Number: PB2485

    Appropriateness of Direct Oral Anticoagulant Prescriptions in Emergency Department Outpatients with Acute Deep Vein Thrombosis

    J. Tabah1, C. Simard2, V. Tagalakis3, M. Koolian3

  • Abstract Number: PB0535

    APTT Clot Waveform Analysis: A Tool in Prediction of Pre-Analytical Errors in Short APTT- Retrospective Analysis

    R. Phatale1, S. Kannan2, S. Apte2

  • Abstract Number: PB0702

    APTT Mixing Studies in the Preoperative Setting

    M. Nomdedeu1, E. Cañamero2, E. Sarrate3, M. Sorigue1, J. Grau1, A. Mesa1, L. Ruiz4, F. Exposito5, M. Comes2, A. Espasa2, E. Orna1, I. Hernandez1, C. Morales5, T. Navarro1

  • Abstract Number: PB0339

    aPTT Reaction Curves Provide Important Additional Information in Hemophilia Patients

    J. Pavic1, M. Milos2, D. Coen Herak2, R. Zadro2,3

  • Abstract Number: PB2112

    Are Patients with an Active Cancer and those with a History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding while on Anticoagulants?

    C. Frere1,2, M. Lejeune1, N. Janus3

  • Abstract Number: PB0219

    Are the Plasma Levels Thresholds of DOAC Rationale and Appropriate for Clinical Decision-making? A Reappraisal Using Thrombin Generation Testing

    J. Evrard1, J.-M. Dogné1,2, M. Hardy3,4, S. Lessire3, V. Maloteau1, L. Morimont1,5, F. Mullier4, R. Siriez1, J. Douxfils1,5

  • Abstract Number: PB0244

    Are Therapeutic Immunoglobulins Free from Factor XIa?

    H. Wilmot, E. Gray

  • Abstract Number: PB2220

    Are We Choosing Wisely? Heritable Thrombophilia (HT) Testing in a District General Hospital in the UK

    L. Khalil

  • Abstract Number: PB1296

    Arterial Ischemic Stroke in Greek Infants, Children and Adolescents: a Single-Centre Experience

    A. Dettoraki1, A. Michalopoulou1, L. Ioannidou2, A. Komitopoulou1, M. Gavra3, P. Xafaki1, Z. Kapsimali1, H. Pergantou1

  • Abstract Number: PB0642

    Artificial Intelligence to Identify Neutrophil Extracellular Traps in Peripehral Blood Smears

    K. Ikemura1, M. Barouqa1, K. Fedorov2, M. Kushnir2, H. Billett2, M. Reyes-Gil1

  • Abstract Number: PB1366

    Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura

    L.P. de Carvalho1, M.P. Colella2, J.M. Annichino-Bizzacchi3, T.D. Martins4

  • Abstract Number: PB1055

    ASCVD Risk Score among Haemophilia Patients: Time to Formally Evaluate Cardiovascular Risk in People with Haemophilia

    R. Camelo1,2,3, B.P. Duarte2, M.C.B. Moura2, N.C.M. Costa2, I.M. Costa2, C.G.P. Roncal2, A.M. Vanderlei2, T.M.R. Guimaraes2, C. Caram Deelder3,4, S.C. Gouw3, S.M. Rezende1, J.G. van der Bom3,4

  • Abstract Number: PB2145

    Aspects of Cancer-Related Venous Thrombosis in a cohort of 207 Tunisian Patients

    M. Mama1, F. Said1, I. Naceur1, H. Baccouche2, I. Ben Ghorbel1, M. Lamloum1, M.H. Houman1, N. Ben Romdhane2

  • Abstract Number: PB0060

    Aspirin Antiplatelet Effects Are Associated with Body Weight

    P. Mourikis1, S. Zako1, L. Dannenberg1, C. Helten1, D. Naguib1, T. Hohlfeld2, T. Petzold3, B. Levkau4, T. Zeus1, M. Kelm1, A. Polzin1

  • Abstract Number: PB1150

    Assay of Emicizumab Using the Modified One-Stage Clotting Assay

    H. Wilmot, E. Gray

  • Abstract Number: PB1260

    Assessing Anticipatory Guidance Needs in Adolescents with Bleeding Disorders

    D. Cortes, J. Shao, M. Reyes

  • Abstract Number: PB1688

    Assessing Platelet Function in Large Cohorts, a Means to Donor Stratification

    J. Dunster1, A. Bye2, N. Kriek2, T. Sage2, C. Kempster2, H. McKinney3, J. Batista3, P. Thomas3, W. Ouwehand3, K. Downes3, A. Unsworth4, J. Gibbins2

  • Abstract Number: PB0897

    Assessing the Bleeding Phenotype in Non-Severe hemophilia by use of the ISTH Bleeding Assessment Tool (BAT)

    F.R. Kloosterman1, A. Zwagemaker1, C.N. Bagot2, E.A.M. Beckers3, J.G. van der Bom4, P. Collins5, M.H. Cnossen6, M. Coppens7, S.C. Gouw1,4, B.A.P. Laros-van Gorkum8, S. Mangles9, F.J.M. van der Meer10, K. Meijer11, L. Nieuwenhuizen12, R. Schutgens13, K. Fijnvandraat1

  • Abstract Number: PB0605

    Assessing the Effect of Freezing and Thawing of Samples for Anti-Factor Xa Testing for the Determination of Enoxaparin Activity

    S. Louw1,2, R. Gounden1,2, E.S. Mayne2,3, J. Vaughan1,2

  • Abstract Number: PB0050

    Assessing the Impact of Switching to the Tobacco Heating System on Cardiovascular Disease: Translating Basic Science into Clinical Benefit

    C. Pater, G. Baker, G. de la Bourdonnaye, A. Elamin, C. Goujon, C. Haziza, A. Heremans, J. Hoeng, N. Ivanov, F. Luedicke, S. Maeder, B. Philips, P. Picavet, S. Pouly, C. Poussin, P. Pratte, C.T. Tran, P. Vanscheeuwijck, M. Peitsch

  • Abstract Number: PB0534

    Assessing the Quality of Interpretative Comments for Prolonged Activated Partial Thromboplastin Time and Mixing Tests

    J.M. Bauça, É. Ajzner, J. Cadamuro, A. Hillarp, A.H. Kristoffersen, P. Meijer

  • Abstract Number: PB1904

    Assessment and Comparison of Acquired Activated Protein C Resistance with Two Thrombin Generation Methods, CAT and ST-Genesia, in APS and SLE Patients

    P.J. Lane1, I. Mackie1, D. Isenberg2,3, H. Cohen1,4, M. Efthymiou1

  • Abstract Number: PB2057

    Assessment and Predictors of Inappropriate Dose of Direct Oral Anticoagulants

    M. Almegren1, M. Alotaibi2, M. Alghafis2, M. Al-Alwan2, S. Alshehri2, M. Almulla2, L. Zaid2

  • Abstract Number: PB0279

    Assessment of Coagulation Factor Levels in LVAD Patients Following Temporary Warfarin Reversal with 4F-PCC (KVAD Study)

    J. Rimsans1, K.W. Sylvester1, L. Coakley2, E. Matiello-Lyons2, K. Frankel2, M. Hickey2, F. Melanson2, M.M. Givertz2, J.M. Connors3

  • Abstract Number: PB2545

    Assessment of Endocan as a Marker for Preeclampsia and Its Clinical Forms

    A. Lopes1, L. Dusse2, S. Martins1, M. Carvalho3, P. Alpoim1

  • Abstract Number: PB0599

    Assessment of ExpertCor, a New Set of Frozen Plasmas for Assay Comparability Studies

    D. Yirga1, J.-B. Baudier2, A. Carlo3, P. Bourgeat2

  • Abstract Number: PB2188

    Assessment of Fibrinolysis Markers in Patients with Lower Limb Deep Venous Thrombosis: A Prospective Case-control Study

    S. Sharma1, V. Uppal2, N. Kumar2, H. Renee2, J. Ahluwalia2, R. Das2, N. Varma2, P. Malhotra2

  • Abstract Number: PB0236

    Assessment of Four Factor Prothrombin Complex Concentrate (4F-PCC) Usage in Emergency Department Patients: A Single Center Experience

    H. McRae, F. Kara, R. Baum, N. Acquisto, M. Refaai

  • Abstract Number: PB0712

    Assessment of in vitro Effects of Direct Thrombin Inhibitors on Activation of Coagulation Factor XIII through Enzyme Kinetics in the Synthetic Substrate-Based Assay

    Y. Fujimori1, M. Wakui2, S. Nakamura3, Y. Kondo3, Y. Ozaki3, S. Oka3, T. Nakagawa3, H. Katagiri3, M. Murata2

  • Abstract Number: PB1481

    Assessment of Platelet Function after Shear Stress Simulation Using an ex vivo Model for Extracorporeal Circulation

    O. Hidiatov1, I. Marini1, L. Pelzl1, F. Rigoni1, M. Wagner1, A. Straub2, T. Bakchoul1,3

  • Abstract Number: PB2561

    Assessment of Post-partum Haemorrhage Risk among Women with Thrombocytopenia: A Cohort Study

    S. Arcudi1, A. Ronchi2, M.W. Ossola2, E. Iurlaro2, M. Capecchi3,4, A. Artoni3, F. Peyvandi1,3

  • Abstract Number: PB2214

    Assessment of Radiological Signs of Chronic Thromboembolic Pulmonary Hypertension on CTPAs Performed for Acute Pulmonary Embolism Leads to Earlier Diagnosis of CTEPH

    G.J.A.M. Boon1, P.M. Jairam2, G.M.C. Groot3, C.J. van Rooden4, Y.M. Ende-Verhaar1, L.F. Beenen5, L.J.M. Kroft6, H.J. Bogaard7, M.V. Huisman1, P. Symersky8, A. Vonk Noordegraaf7, L.J. Meijboom5, F.A. Klok1

  • Abstract Number: PB0609

    Assessment of the CN-6000; a Novel, High-Speed Coagulation Analyser, Utilising Coagulation, Chromogenic, Immuno-Turdibimetric and Light Transmission Aggregation Technologies

    A. Woolley1, S. Kitchen1, I. Patel2, R. Wardle1

  • Abstract Number: PB0303

    Assessment of the Difference Between EXTEM and FIBTEM Amplitudes (PLTEM) and Their Correlation with Platelet Count (PLT), and the Effect of Fibrinogen and Hematocrit (HTC) in Cardiovascular Surgery (CVS)

    M.S. López1,2, F.G. Mileo3, L.H. Barrera1,4, J. Oyhamburu2,5, M.E. Martinuzzo2,5

  • Abstract Number: PB1408

    Assessment of the Hemostatic System by Total Thrombus-formation Analysis System (T-TAS) in Patients with Chronic Coronary Syndromes

    O. Sirotkina1,2, I. Nazarova1, O. Melnichnikova1, A. Panov1, T. Vavilova1

  • Abstract Number: PB2121

    Assessment of the Ottawa Score in the Prediction of Recurrent Venous Thromboembolism in Patients Treated for Lymphoma

    J. Rupa-Matysek1, A. Hoppe1, M.M. Joks2, M. Joks1, L. Gil1

  • Abstract Number: PB1653

    Assessment of Thrombus Formation under Flow-Conditions in Essential Thrombocythemia/ Polycythemia Vera

    Y. Ikeda1, T. Hato1, A. Watanabe2, J. Yamanouchi1, K. Takenaka1

  • Abstract Number: PB1109

    Assessment of Vector Integration of AAV5-hFIX in Mice and Non-human Primates Indicates No Association with Tumorigenic Risk

    L. Spronck, M. de Haan, L. Heijink, J. Twisk, V. Ferreira, S. van Deventer

  • Abstract Number: PB1256

    Assessment of Vitamin K Level in Newborn Presenting with Bleeding in Population of Rural Sindh, Pakistan

    N. Hafeez1, I. Ujjan1, S. Tabassum1, K. Aamir1, A. Naz2

  • Abstract Number: PB1012

    Association Between Aging and Health Status in Persons Leaving with Hemophilia and Controls Without a Bleeding Disorder – Insights from the PROBE Study

    F. Germini1,2, S. O'Callaghan3, C. Chai-Adisaksopha2,4, R. Curtis5, N. Frick6, M. Nichol7, D. Noone8,9, B. O'Mahony10, D. Page11, J. Stonebraker12, M. Skinner1,13, A. Iorio1,14, PROBE investigators

  • Abstract Number: PB2461

    Association Between Index VTE Event and 12-Months Outcomes for Patients in Routine Clinical Practice Enrolled in the ETNA-VTE-Europe Registry

    M. Coppens1, A.T. Cohen2, C. Ay3, P. Hainaut4, U. Hoffmann5, S. Gaine6, D. Jiménez7, M. Schindewolf8, B. Brüggenjürgen9, P. Levy10, J. López Bastida11, E. Vicaut12, P. Bramlage13, G. Agnelli14, ETNA-VTE-Europe Investigators

  • Abstract Number: OC 10.1

    Association between Initial and Residual Pulmonary Vascular Obstruction and Venous Thromboembolism Recurrence, a Pooled Analysis

    R. Chaux1, O. Sanchez2,3, F. Couturaud2,4, N. Meneveau5, E. Presles1,6,7, R. Chopard5, L. Bertoletti6,7,8, P. Mismetti2,6,8, S. Laporte1,7,9, E. Ollier1,7

  • Abstract Number: PB1056

    Association between Platelet Glycoprotein Common SNVs and Bleeding Severity in Haemophilia Patients

    L. Bury1, G. Piroli1, H. Kuchi Bhotla1, M. Borghi1, E. Cesari1, E. Falcinelli1, R. De Cristofaro2,3, B. Zieger4, P. Gresele1

  • Abstract Number: PB0825

    Association of Adherence and Bleeding Frequency among Severe Hemophilia A Patients on Prophylactic Factor VIII

    F. Mohd Mokhtar1,2, J. Sathar3, P.C. Bee4, H. Zaman Huri5

  • Abstract Number: PB2080

    Association of Body Mass Index (BMI) with Bleeding Events in Patients Taking Oral Anticoagulation for Atrial Fibrillation (AF) or Venous Thromboembolism (VTE)

    T. Feldeisen1, X. Kong1, E. Kline-Rogers1, C. Alexandris-Souphis1, B. Haymart1, D. DeCamillo1, S. Kaatz2, M. Ali3, J. Kozlowski4, V. Shah5, G.D. Barnes1, J.B. Froehlich1

  • Abstract Number: PB2060

    Association of Clinical Risk Factors and Biomarkers with Thromboembolism, Major Bleeding, and All-Cause Death in Patients with Atrial Fibrillation in a Tertiary Care Setting

    D. Kraemmer, O. Königsbrügge, S. Nopp, I. Pabinger, C. Ay

  • Abstract Number: PB1515

    Association of Genetic Variability in Selected Genes in Patients with Deep Vein Thrombosis and Platelet Hyperaggregability

    L. Lisá, J. Sokol, J. Ivanková, J. Zolkova, L. Vadelova, I. Plamenova, J. Stasko

  • Abstract Number: PB0028

    Association of MMP-12 and SDF1 with Symptomatic and Asymptomatic Atherosclerosis

    M. Marcos Jubilar1, J.C. Pastrana2, J. Orbe3,4,5, C. Roncal3,4,5, J.A. Rodriguez3,4,5, A. Fernández-Montero6, R. Rodil7, I. Colina8, J.A. Páramo1,4,5

  • Abstract Number: PB1885

    Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

    J.T.d.S. Castro1, B.D.M. Mazetto2, A.P. Rosa2, G. Yamagutti3, M. Colella3, E.V. Paulo3, J.A. Bizachi3, F. Reis1, F.A. Orsi3

  • Abstract Number: PB1621

    Association of Platelet Derived – Microparticles and Endothelia Dysfunction in NVAF Patients Undertaking PCI

    B. Ding1, L. He2, Y. Zhou1

  • Abstract Number: PB2251

    Association of Portal Vein Thrombosis and Clinical Outcomes in Cirrhotic Patients: A Nested Case-Control Study

    P. Tavornshevin, A. Leerapun, E. Rattarittamrong, L. Norrasethada, P. Piriyakhuntorn, S. Hantrakool, A. Tantiworawit, T. Rattanathammethee, C. Chai-Adisaksopha

  • Abstract Number: PB2333

    Association of Surgical and Medical Hospitalizations with Venous Thromboembolism (VTE) in a Primary Care Population

    X. Jordan Bruno1, I. Koh2, T.B. Plante3, C.E. Holmes4, R. Walker5, P. Lutsey6, A.B. Repp7, M. Cushman8, N.A. Zakai9

  • Abstract Number: PB0943

    Associations between Physical Activity Levels and Bleeding Frequency in People with Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study

    F. Nissen1, T. Burke2, S. Asghar2, A. Shang1, M. Aizenas1, O. Meier1, J. O'Hara2,3

  • Abstract Number: PB1984

    Astrocytes Are Central Contributors in Restoration of the Blood Brain Barrier via Transcriptional Upregulation of Key Gap Junction Proteins between Endothelial Cells

    P. Stafford1, S. Mitra1, A. Stem1, P. Lutz1, J. Hadley1, A. D'Alessandro2, K. Jones3, C. Silliman4, E. Moore1, M. Cohen1

  • Abstract Number: PB1266

    Asymptomatic Catheter Related Thrombosis in Neonates: The Role of Thrombophilia Testing

    B. Allahyani1,2, A. Lesleigh1, R. Ljung2

  • Abstract Number: PB1018

    ATHN 7: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Hemophilia-Demographics and Preliminary Results

    T. Buckner1, N. Daoud2, S.E. Croteau3, C.L. Kempton4, L. Malec5, J. Staber6, M. Wang1, C. Watson2, M. Recht2

  • Abstract Number: PB1331

    Atorvastatin Restores the Imbalance of CD4+ T cells in Immune Thrombocytopenia via Ras/MEK/ERK and mTOR/PI3K/AKT Pathways

    P. Xu1, M. Xu2, M. Hou2

  • Abstract Number: PB2088

    Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management

    P. Collins1, A. Lewin1, N. Vincze Irving1, K. Sylvester1, J. Fanikos1, S.Z. Goldhaber2, J.M. Connors3

  • Abstract Number: PB1605

    Autoantibody Mediated Changes in Megakaryocytes Glycan Pattern: Potential Impact on Thrombopoiesis in Immune Thrombocytopenia

    I. Marini1, J. Zlamal1, L. Pelzl1, K. Althaus1,2, T. Bakchoul1,2

  • Abstract Number: PB0782

    Autoimmune Acquired Factor XIII Deficiency: A Case Report

    A. Marco1,2, A. Garzo1,2, E. Campos1,2, L. Tomas1,2, P. Marco1,2,3

  • Abstract Number: PB1414

    Autoimmune Heparin-Induced Thrombocytopenia Successfully Treated using Direct Oral Anticoagulant and Intra-Venous Immunoglobulin

    E.-M. Walle1, O. Chassin2, N. Legris2, N. Chanson3, V. Proulle1

  • Abstract Number: PB1862

    Automated Chemiluminescent ADAMTS13 Activity Immunoassay for Thrombotic Thrombocytopenic Purpura Diagnosis and Follow-up

    N. Beranger1,2, S. Benghezal1,2, B. Joly1,2, S. Capdenat1,2, A. Delton1,2, A. Stepanian1,2, P. Coppo3, A. Veyradier1,2

Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley